| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4935410 | Seizure | 2017 | 6 Pages |
Abstract
In our clinical setting, generic LEV was determined to be bioequivalent to brand LEV. Furthermore, seizures frequency or/and adverse events were not affected upon switching from brand to generic LEV.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Sofia Markoula, Dimitrios Chatzistefanidis, Stylianos Gatzonis, Anna Siatouni, Eleftheria Siarava, Anastasia Verentzioti, Athanassios P Kyritsis, Philip N. Patsalos,